Search research articles
Contact Us
Filters
Showing results (131-140 of 227) with videos related to
Page
of 23
Sort By:
The Journal of Infectious Diseases
|
October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients
Francesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
Antiviral Therapy
|
November 13, 2004
Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems
Andrea De Luca, Alessandro Cozzi-Lepri, Carlo-Federico Perno, et al.
Open Forum Infectious Diseases
|
January 9, 2018
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015
Dominic E Dwyer, Ruth Lynfield, Marcelo H Losso, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 30, 2026
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?
Giulia Micheli, Annalisa Mondi, Ashley Roen, et al.
The Journal of Infectious Diseases
|
June 3, 2006
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads
Alessandro Cozzi-Lepri, Andrea De Luca, Andrew N Phillips, et al.
Viruses
|
January 8, 2025
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic
Alessandra Vergori, Nicola Gianotti, Alessandro Tavelli, et al.
Scientific Reports
|
August 18, 2025
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease
Ilaria Mastrorosa, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Travel Medicine and Infectious Disease
|
April 3, 2022
Prevalence of Chagas disease and strongyloidiasis among HIV-infected Latin American immigrants in Italy - The CHILI study
Paola Rodari, Francesca Tamarozzi, Stefano Tais, et al.
Microorganisms
|
August 14, 2020
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period
E Franceschini, Antonella Santoro, Marianna Menozzi, et al.
Journal of Global Antimicrobial Resistance
|
January 30, 2025
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units
Andrea De Vito, Antonia Bezenchek, Rossana Scutari, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 227) with videos related to
Sort By:
Page
of 23
The Journal of Infectious Diseases
|
October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients
Francesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
Antiviral Therapy
|
November 13, 2004
Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems
Andrea De Luca, Alessandro Cozzi-Lepri, Carlo-Federico Perno, et al.
Open Forum Infectious Diseases
|
January 9, 2018
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015
Dominic E Dwyer, Ruth Lynfield, Marcelo H Losso, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 30, 2026
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?
Giulia Micheli, Annalisa Mondi, Ashley Roen, et al.
The Journal of Infectious Diseases
|
June 3, 2006
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads
Alessandro Cozzi-Lepri, Andrea De Luca, Andrew N Phillips, et al.
Viruses
|
January 8, 2025
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic
Alessandra Vergori, Nicola Gianotti, Alessandro Tavelli, et al.
Scientific Reports
|
August 18, 2025
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease
Ilaria Mastrorosa, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Travel Medicine and Infectious Disease
|
April 3, 2022
Prevalence of Chagas disease and strongyloidiasis among HIV-infected Latin American immigrants in Italy - The CHILI study
Paola Rodari, Francesca Tamarozzi, Stefano Tais, et al.
Microorganisms
|
August 14, 2020
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period
E Franceschini, Antonella Santoro, Marianna Menozzi, et al.
Journal of Global Antimicrobial Resistance
|
January 30, 2025
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units
Andrea De Vito, Antonia Bezenchek, Rossana Scutari, et al.
Page
of 23